Efficacy and safety of CT-P39, an omalizumab biosimilar, in chronic spontaneous urticaria: 16-week follow-up study
CT-P39(一种奥马珠单抗生物类似药)治疗慢性自发性荨麻疹的疗效和安全性:16周随访研究
期刊:Clinical and Translational Allergy
影响因子:4
doi:10.1002/clt2.70069
Grattan, Clive; Dytyatkovska, Yevgeniya; Springer, Michał; Ratkova, Maria; Krusheva, Borislava; Krupa-Borek, Izabella; Pulka, Grazyna; Chełmińska, Marta; Reich, Adam; Kim, Sunghyun; Bae, Yunju; Kim, Suyoung; Lee, Sewon; An, Eunjin; Park, Jeong Eun; Ka, Jieun; Kim, Jongho; Saini, Sarbjit S